Insider Trading Alert - WMGI, COST, ACAS, TRLA And IRBT Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 16, 2013, 116 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $164.25 to $16,145,446.22.

Highlighted Stocks Traded by Insiders:

Wright Medical Group (WMGI) - FREE Research Report

Berry Lance A who is Sr. VP & CFO at Wright Medical Group sold 965 shares at $29.46 on Dec. 16, 2013. Following this transaction, the Sr. VP & CFO owned 65,916 shares meaning that the stake was reduced by 1.44% with the 965-share transaction.

Walker Jennifer S. who is SVP, Process Improvement at Wright Medical Group sold 567 shares at $29.42 on Dec. 16, 2013. Following this transaction, the SVP, Process Improvement owned 36,210 shares meaning that the stake was reduced by 1.54% with the 567-share transaction.

The shares most recently traded at $28.58, down $0.84, or 2.94% since the insider transaction. Historical insider transactions for Wright Medical Group go as follows:

  • 4-Week # shares sold: 8,310
  • 12-Week # shares sold: 8,310
  • 24-Week # shares sold: 8,310

The average volume for Wright Medical Group has been 431,300 shares per day over the past 30 days. Wright Medical Group has a market cap of $1.4 billion and is part of the health care sector and health services industry. Shares are up 39.73% year-to-date as of the close of trading on Monday.

Wright Medical Group, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of devices and biologic products for the extremity, hip, and knee repair and reconstruction. The company operates through two segments, Extremities and OrthoRecon. Currently there are 6 analysts that rate Wright Medical Group a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WMGI - FREE

TheStreet Quant Ratings rates Wright Medical Group as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full Wright Medical Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Costco Wholesale Corporation (COST) - FREE Research Report

Sinegal James D who is Director at Costco Wholesale Corporation sold 8,000 shares at $117.92 on Dec. 16, 2013. Following this transaction, the Director owned 915,294 shares meaning that the stake was reduced by 0.87% with the 8,000-share transaction.

The shares most recently traded at $117.26, down $0.66, or 0.56% since the insider transaction. Historical insider transactions for Costco Wholesale Corporation go as follows:

  • 4-Week # shares sold: 66,946
  • 12-Week # shares sold: 106,802
  • 24-Week # shares sold: 130,802

The average volume for Costco Wholesale Corporation has been 1.8 million shares per day over the past 30 days. Costco Wholesale Corporation has a market cap of $51.5 billion and is part of the services sector and retail industry. Shares are up 19.52% year-to-date as of the close of trading on Monday.

Costco Wholesale Corporation, together with its subsidiaries, operates membership warehouses. The company offers branded and private-label products in a range of merchandise categories. The stock currently has a dividend yield of 1.05%. The company has a P/E ratio of 25.4. Currently there are 12 analysts that rate Costco Wholesale Corporation a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on COST - FREE

TheStreet Quant Ratings rates Costco Wholesale Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, growth in earnings per share, increase in net income and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Costco Wholesale Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

American Capital (ACAS) - FREE Research Report

Harper Philip R who is Director at American Capital sold 15,000 shares at $14.76 on Dec. 16, 2013. Following this transaction, the Director owned 1.4 million shares meaning that the stake was reduced by 1.07% with the 15,000-share transaction.

The shares most recently traded at $14.51, down $0.25, or 1.73% since the insider transaction. Historical insider transactions for American Capital go as follows:

  • 4-Week # shares sold: 19,639
  • 12-Week # shares bought: 15,000
  • 12-Week # shares sold: 88,870
  • 24-Week # shares bought: 15,000
  • 24-Week # shares sold: 104,238

The average volume for American Capital has been 2.0 million shares per day over the past 30 days. American Capital has a market cap of $4.1 billion and is part of the financial sector and financial services industry. Shares are up 21.96% year-to-date as of the close of trading on Monday.

American Capital, Ltd. is a private equity and venture capital firm specializing in management and employee buyouts, leveraged finance, mezzanine, acquisition, recapitalization, middle market, and growth capital investments. The company has a P/E ratio of 22.9. Currently there are 3 analysts that rate American Capital a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACAS - FREE

TheStreet Quant Ratings rates American Capital as a hold. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full American Capital Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Trulia (TRLA) - FREE Research Report

Inkinen Sami who is Director at Trulia sold 5,800 shares at $31.07 on Dec. 16, 2013. Following this transaction, the Director owned 885,553 shares meaning that the stake was reduced by 0.65% with the 5,800-share transaction.

Flint Peter who is Chief Executive Officer at Trulia sold 8,000 shares at $31.08 on Dec. 16, 2013. Following this transaction, the Chief Executive Officer owned 1.4 million shares meaning that the stake was reduced by 0.56% with the 8,000-share transaction.

The shares most recently traded at $31.13, up $0.05, or 0.16% since the insider transaction.

The average volume for Trulia has been 1.3 million shares per day over the past 30 days. Trulia has a market cap of $1.2 billion and is part of the technology sector and internet industry. Shares are up 92% year-to-date as of the close of trading on Monday.

Trulia, Inc. provides tools to research homes and neighborhoods for consumers through Web and mobile applications. The company, through its tools, also enables real estate professionals to market their listings. The company has a P/E ratio of 211.5. Currently there are 3 analysts that rate Trulia a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on TRLA - FREE

TheStreet Quant Ratings rates Trulia as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that net income has been generally deteriorating over time. Get the full Trulia Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

iRobot Corporation (IRBT) - FREE Research Report

Gansler Jacques S who is Director at iRobot Corporation sold 5,000 shares at $29.84 on Dec. 16, 2013. Following this transaction, the Director owned 7,412 shares meaning that the stake was reduced by 40.28% with the 5,000-share transaction.

The shares most recently traded at $37.53, up $7.69, or 20.49% since the insider transaction. Historical insider transactions for iRobot Corporation go as follows:

  • 24-Week # shares sold: 1,343

The average volume for iRobot Corporation has been 449,700 shares per day over the past 30 days. iRobot Corporation has a market cap of $847.2 million and is part of the consumer goods sector and consumer durables industry. Shares are up 56.62% year-to-date as of the close of trading on Monday.

iRobot Corporation designs, develops, and markets robots for the consumer, government, and industrial markets worldwide. It offers consumer products, including floor vacuuming and washing robots, floor sweeping robots, and pool and gutter cleaning robots. The company has a P/E ratio of 46.6. Currently there are 2 analysts that rate iRobot Corporation a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IRBT - FREE

TheStreet Quant Ratings rates iRobot Corporation as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full iRobot Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers